$OPXA News Opexa, BreitBurn, Hudson Pacific price

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$OPXA News

Opexa, BreitBurn, Hudson Pacific price offerings 12:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 9:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 4:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 12:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 10:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy

US Stock Futures Up; Fed Decision In Focus 5:49 a.m. Dec. 18, 2013 - benzinga.com
Opexa Therapeutics Prices 4.12M Share Offering at/$1.70/Share 4:58 a.m. Dec. 18, 2013 - benzinga.com
Opexa Converts all Convertible Secured Promissory Notes into Common Stock 4:32 a.m. Sept. 25, 2013 - benzinga.com
Weekly CFO Buys Highlight 11:32 a.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 1:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 2:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 8:56 a.m. Aug. 8, 2013 - 247WallSt.com
Opexa Therapeutics Prices 12M Share Offering at $1.50/Share 8:06 p.m. Aug. 7, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 2:36 p.m. Aug. 7, 2013 - 247WallSt.com
Morning Market Losers 8:09 a.m. May 14, 2013 - benzinga.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 2:25 a.m. April 8, 2013 - InvestorPlace.com
10-K: OPEXA THERAPEUTICS, INC. 8:16 a.m. March 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 8:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 2:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 8:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 9:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 3:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 2:22 p.m. Feb. 14, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com


Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 10:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 9:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 4:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 8:00 a.m. Dec. 16, 2013 - BusinessWire
New Supply Agreements and Analytical Tools, Expansions, Conference Presentations and Financial Results - Research Report on WuXi PharmaTech, Sirona, ICON, Opexa Therapeutic and Karyopharm Therapeutics 9:04 a.m. Nov. 20, 2013 - PR Newswire
Opexa Therapeutics Selected as a "Top 10 Advanced Therapy Projects to Watch" 9:00 a.m. Nov. 12, 2013 - BusinessWire
Opexa CEO Invited to Join Personalized Medicine Panel at New York CEO Conference 9:00 a.m. Nov. 8, 2013 - BusinessWire
Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update 4:05 p.m. Nov. 7, 2013 - BusinessWire
CORRECTING and REPLACING Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:51 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:00 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS 8:00 a.m. Oct. 23, 2013 - BusinessWire
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews 8:00 a.m. Oct. 21, 2013 - BusinessWire
Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24 12:01 p.m. Oct. 18, 2013 - GlobeNewswire
The RedChip Money Report TV Show Now Airing Weekly on Bloomberg Europe: 139 Million Homes 10:30 a.m. Oct. 17, 2013 - GlobeNewswire
Opexa Therapeutics CEO to Appear on The RedChip Money Report on Fox Business News 8:00 a.m. Oct. 17, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 4:15 p.m. Oct. 8, 2013 - BusinessWire
Opexa Therapeutics' CEO Featured in Leading Life Science Publication 8:00 a.m. Oct. 7, 2013 - BusinessWire
Opexa Therapeutics' Therapy for Multiple Sclerosis Featured in FOX Television News Story 8:00 a.m. Oct. 2, 2013 - BusinessWire
Opexa CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting 8:00 a.m. Sept. 30, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 3

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 6

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 1

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 0

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 5

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 0

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 2

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

EEW Renewables and CDAQ Plan Major Business Move Together

Updated Category News Views 57

EEW Renewables and CDAQ Unveil Investor Webcast for Business Combination EEW Renewables Ltd, a leader in the renewable energy sector, has teamed up with Compass Digital Acquisition Corp, commonly known as CDAQ, to announce the release of an investor webcast aimed at discussing their proposed business combination. The webcast features insightful presentations from the...

Continue Reading
Investors Can Take Action in Integer Holdings Lawsuit Today

Updated Category News Views 131

Opportunities for Integer Holdings Investors Recently, Integer Holdings Corporation (NYSE: ITGR) has opened the door for investors to engage actively in a securities fraud lawsuit. This comes as the Rosen Law Firm, known for its expertise in investor rights, brought attention to a class action concerning common stock purchases made between July 25, 2024 and October 22,...

Continue Reading
Controversial Legal Battle Unfolds at FNZ Amid Equity Tensions

Updated Category News Views 365

FNZ Directors Face Employee Shareholder Backlash In a surprising twist in the ongoing legal saga surrounding FNZ, the two directors representing major shareholders have taken significant steps to impede a USD $4.6 billion class action initiated by employee shareholders. This action raises serious concerns about corporate governance and the rights of employees within the...

Continue Reading
Unity in the Cannabis Industry: A New Path Forward

Updated Category News Views 88

Time for Unity in the Cannabis Industry Recent changes in the hemp and cannabis industries have underscored how vital collaboration is. Experts in the field are pushing for a stronger partnership between these sectors to advocate for clear and coherent federal regulations. The Current Situation Tensions are rising across several states. For instance, Florida's hemp...

Continue Reading
Daiso Launches New Store in San Antonio's Shopping Hub

Updated Category News Views 314

Exciting New Daiso Store Opening Daiso, a global retail sensation, is set to debut its latest store at Thousand Oaks Shopping Center. This opening is generating buzz among shoppers looking for affordable and unique merchandise. The store is designed to cater to a diverse range of tastes and needs, and it's perfectly timed for the upcoming shopping season. Store Features...

Continue Reading